Trial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer Subjects
Clinical trial NCT02310464 · COMPLETED
Trial details
- NCT number
- NCT02310464
- Sponsor
- OBI Pharma, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-22
- Primary completion
- 2020-12-22
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.